How does antibody quantification work on Amperia™❓ In this short How It Works video 📹, Matthew Reaney explains the inverse occupancy assay and when to use Protein A vs Protein G.

🔬 Measuring total AAV capsids in cell and gene therapy. Dominykas Zala explains sandwich immunoassay–based total capsid quantification on Amperia™.

Leadership update at Abselion: Paolo Romele → SVP of Technology Kim Orton-Smith → SVP of Commercial Strengthening both technical leadership and commercial execution as we scale.

🧪Fast answers for His-tagged protein quantification. 📹In this short How It Works video, Matthew Reaney explains the premix competition assay on Amperia™ for expression screening.

Two weeks to go until BPI US West 2026🌴BioProcess Intl. We’ll be on site in San Diego — looking forward to great conversations and familiar faces.

Barcelona in two weeks We’ll be on site at Bioprocessing Summit Europe 2026 — looking forward to good conversations and fresh ideas. #BPSMTeu

🔬 Three biologics. Three quantification formats. Antibodies • AAV capsids • His-tagged proteins — explained by the scientists who run the assays. ▶️ Watch the series: abselion.com/resources/

One week to go until BPI US West 2026 ⏳BioProcess Intl. Looking forward to being in San Diego and connecting with the bioprocessing community.

One week to go until Bioprocessing Summit Europe 2026 ⏳ Looking forward to a great few days in Barcelona. #BPSMTeu

BPI US West starts tomorrow! ✈️ We’ll be on site in San Diego — see you there! BioProcess Intl.

Big milestone for Abselion — we’ve officially established our US subsidiary in Cambridge, MA, based at The Engine The Engine. Strengthening our North American presence to support closer collaboration across biologics R&D. 🇺🇸🔬 More to come.

Barcelona, we’re on our way ✈️ See you tomorrow at Bioprocessing Summit Europe 2026. #BPSMTeu

Two weeks to go until NextGenBiomed 2026 We’ll be exhibiting at Booth 71 — looking forward to good in-person conversations.NextGen Biomed

One week to go until NextGenBiomed 2026 ⏳ Catch us at Booth 71 next week. NextGen Biomed

Delighted that Abselion has been shortlisted for Biotech Company of the Year at the Independent Science & Technology Awards 2026 🎉 Cambridge Independent Looking forward to the awards evening! cambridgeindependent.co.uk/business/final…

📢Abselion appoints Dale Gordon as Chair of the Board. With 30+ years of life sciences leadership experience, Dale joins as the company continues its international growth and recent US expansion. Read more: abselion.com/abselion-appoi…

Ready for NextGenBiomed 2026 We’ll be at Booth 71 from tomorrow. NextGen Biomed

Two weeks until BioProcess Intl. Europe 2026 🇦🇹 The Abselion team will be on site in Vienna — looking forward to a few days of focused, in-person conversations.

Dale Gordon, who recently joined Abselion as Chair, shares his perspective in a new interview with BioTechniques on how life science technologies move from innovation into real-world use. 🔗biotechniques.com/lab-design-mac…

One week to go until BioProcess Intl. Europe 2026 We’ll be in Vienna next week — if you’re attending and would like to connect, feel free to reach out.